Japanese Encephalitis - Pipeline Review, H1 2015 is a new market research publication announced by Reportstack. This report provides an overview of the Japanese Encephalitis’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Japanese Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Japanese Encephalitis and special features on late-stage and discontinued projects.
Biological E, one of the leading Indian vaccine manufacturers, has launched a safe and effective vaccine against Japanese Encephalitis, a deadly infectious disease and the leading cause of Acute Encephalitis.